全文获取类型
收费全文 | 1576篇 |
免费 | 89篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 84篇 |
妇产科学 | 14篇 |
基础医学 | 138篇 |
口腔科学 | 146篇 |
临床医学 | 123篇 |
内科学 | 345篇 |
皮肤病学 | 47篇 |
神经病学 | 99篇 |
特种医学 | 262篇 |
外科学 | 100篇 |
综合类 | 59篇 |
预防医学 | 79篇 |
眼科学 | 24篇 |
药学 | 77篇 |
中国医学 | 9篇 |
肿瘤学 | 55篇 |
出版年
2023年 | 6篇 |
2022年 | 9篇 |
2021年 | 10篇 |
2020年 | 14篇 |
2019年 | 20篇 |
2018年 | 17篇 |
2017年 | 19篇 |
2016年 | 13篇 |
2015年 | 27篇 |
2014年 | 59篇 |
2013年 | 80篇 |
2012年 | 60篇 |
2011年 | 64篇 |
2010年 | 61篇 |
2009年 | 79篇 |
2008年 | 56篇 |
2007年 | 77篇 |
2006年 | 50篇 |
2005年 | 48篇 |
2004年 | 32篇 |
2003年 | 25篇 |
2002年 | 31篇 |
2001年 | 22篇 |
2000年 | 29篇 |
1999年 | 34篇 |
1998年 | 85篇 |
1997年 | 61篇 |
1996年 | 68篇 |
1995年 | 51篇 |
1994年 | 52篇 |
1993年 | 49篇 |
1992年 | 22篇 |
1991年 | 9篇 |
1990年 | 17篇 |
1989年 | 43篇 |
1988年 | 28篇 |
1987年 | 31篇 |
1986年 | 23篇 |
1985年 | 16篇 |
1984年 | 21篇 |
1983年 | 16篇 |
1982年 | 14篇 |
1981年 | 20篇 |
1980年 | 14篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1977年 | 17篇 |
1976年 | 11篇 |
1975年 | 13篇 |
1969年 | 5篇 |
排序方式: 共有1674条查询结果,搜索用时 15 毫秒
81.
82.
C Badenas J To-Figueras JD Phillips CA Warby C Muñoz and C Herrero 《Clinical genetics》2009,75(4):346-353
Porphyria cutanea tarda (PCT) arises from decreased hepatic activity of uroporphyrinogen decarboxylase (UROD). Both genetic and environmental factors interplay in the precipitation of clinically overt PCT, but these factors may vary between different geographic areas. Decreased activity of UROD in erythrocytes was used to identify patients with UROD mutations among a group of 130 Spanish PCT patients. Nineteen patients (14.6%) were found to harbor a mutation in the UROD gene. Eight mutations were novel: M1I, 5del10, A22V, D79N, F84I, Q116X, T141I and Y182C. Five others were previously described: F46L, V134Q, R142Q, P150L and E218G. The new missense mutations and P150L were expressed in Escherichia coli. D79N and P150L resulted in proteins that were localized to inclusion bodies. The other mutations produced recombinant proteins that were purified and showed reduced activity (range: 2.3–73.2% of wild type). These single amino acid changes were predicted to produce complex structural alterations and/or reduced stability of the enzyme. Screening of relatives of the probands showed that 37.5% of mutation carriers demonstrated increased urinary porphyrins. This study emphasizes the role of UROD mutations as a strong risk factor for PCT even in areas where environmental factors (hepatitis C virus) have been shown to be highly associated with the disease. 相似文献
83.
84.
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy 总被引:8,自引:0,他引:8
Lodi R Schapira AH Manners D Styles P Wood NW Taylor DJ Warner TT 《Annals of neurology》2000,48(1):72-76
We studied in vivo muscle energy metabolism in patients with Huntington's disease (HD) and dentatorubropallidoluysian atrophy (DRPLA) using 31P magnetic resonance spectroscopy (MRS). Twelve gene-positive HP patients (4 presymptomatic patients) and 2 gene-positive DRPLA patients (1 presymptomatic patient) were studied. 31P-MRS at rest showed a reduced phosphocreatine-to-inorganic phosphate ratio in the symptomatic HD patients and DRPLA patient. Muscle adenosine triphosphate/(phosphocreatine + inorganic phosphate) at rest was significantly reduced in both groups of symptomatic and presymptomatic HD subjects and was below the normal range in the 2 DRPLA subjects. During recovery from exercise, the maximum rate of mitochondrial adenosine triphosphate production was reduced by 44% in symptomatic HD patients and by 35% in presymptomatic HD carriers. The maximum rate of mitochondrial adenosine triphosphate production in muscle was also reduced by around 46% in the 2 DRPLA subjects. Our findings show that HD and DRPLA share a deficit of in vivo mitochondrial oxidative metabolism, supporting a role for mitochondrial dysfunction as a factor involved in the pathogenesis of these polyglutamine repeat-mediated neurodegenerative disorders. The identification of 31P-MRS abnormalities may offer a surrogate biochemical marker by which to study disease progression and the effects of treatment in HD and DRPLA. 相似文献
85.
目的 对比分析下肢骨肉瘤的X线与MRI表现,探讨MRI对骨肉瘤的诊断价值。方法 收集经手术或病理穿刺活检证实的下肢骨肉瘤15例,男11例,女4例,均行MRI平扫及增强扫描(4例行CT扫描),并摄有X线平片,对其MRI征象与X线征象作逐一对比。结果 MRI及X线平片对下肢骨肉瘤的诊断准确率均为100%,MRI在显示病变范围、放射状骨针、Codman三角两层结构以及跳跃病灶等方面明显优于X线平片检查。结论 X线平片是诊断骨肉瘤最简便而实用的方法,但MRI可以更好的显示病变的范围,发现早期病变。 相似文献
86.
Saadat P. Cesnorek S. Ram R. 《世界核心医学期刊文摘》2006,2(8):47-48
神经节细胞瘤是一种神经内分泌肿瘤,其发生与自主神经系统的交感或副交感神经节有关。罕见发生于膀胱、前列腺和子宫。本文作者报道1例发生于儿童头皮的原发性皮肤神经节细胞瘤。对此肿瘤进行了组织学、免疫组化和超微结构研究。该病例可能代表神经嵴细胞向鳃弓发育过程中的一种异常迁移。此外,研究结果还强调在胚胎发育过程中神经嵴和鳃弓/裂之间有复杂的相互作用。 相似文献
87.
Casali C Stefani A Paci M Morandi U Lodi R 《The Journal of cardiovascular surgery》2001,42(2):271-273
The case of a 63-year-old woman with a solitary pulmonary nodule (SPN) is reported. Surgical wedge resection revealed an hamartoma. Digital examination of the lung parenchyma showed an unexpected (not previously visualized by thoracic imaging) second nodule that intraoperative frozen examination revealed an adenocarcinoma. The operation was completed with a right upper lobectomy and complete lymphoadenectomy. The authors recommend an early open surgical procedure for any SPNs with risk factors for developing lung cancer. 相似文献
88.
89.
一例AML中一种新的TCRδ基因重排及其分析方法 总被引:5,自引:0,他引:5
T细胞抗原受体(TCR)功能的表达有赖于该基因在正常T淋巴细胞发育过程中的重排。近年来,已发现一些肿瘤及白血病中出现该基因的异常重排。我们采用聚合链反应(PCR)、“磁珠”固相纯化方法和PCR产物直接测序等方法,从一例AML中发现了一种在白血病中未报道过的TCRδ基因重排,该重排是一种新报道的Dδ区DδX片段的重排,为DδXDδDδJδ不完全重排。在研究白血病TCR基因重排中,采用本文所报道的方法 相似文献
90.
Essential fatty acids are claimed to have positive effects in atopic diseases. In a double blind, placebo controlled, parallel group study 58 out of 60 children, with atopic dermatitis and the need for regular treatment with topical skin steroids, completed a 16 weeks' treatment period with either Epogam evening primrose oil or placebo capsules. Twenty two of these subjects also had asthma. The parents used diaries to record symptom scores and concomitant medication. Peak expiratory flow was measured and disease activity was monitored by the clinician every four weeks. The plasma concentrations of essential fatty acids increased significantly in the group treated with Epogam capsules. The study demonstrated significant improvements of the eczema symptoms but no significant difference was found between the placebo and the Epogam groups. No therapeutic effect was shown on asthma symptoms or fidget. 相似文献